Oral premalignant lesions: a clinicopathological study
DOI:
https://doi.org/10.18203/2349-2902.isj20174520Keywords:
Histopathology, Oral cancer, Potentially malignant oral disordersAbstract
Background: A significant number of oral cancer cases present initially with precursor lesions. If detected earlier in disease course it will reduce the morbidity and mortality. The objective of this study was to evaluate the clinical presentation and various histopathological types of premalignant lesions.
Methods: This is descriptive, observational, analytical type of study of five-year duration. The detail clinical presentation, relevant investigation and histopathological study on biopsy tissue stain with H and E was done and the data is analysed.
Results: During study period, 173 cases having oral lesions were observed. Among these 38 cases showed oral premalignant lesions. The most common age group affected was in between 50 to 59 years. The male predominance was noted. Male to female ratio was 1.9:1. The location of the lesions were buccal mucosa (55.26%), tongue (26.31%), gingiva (7.90%), alveolus (5.26%), lip (2.6%), retromolar area (2.63%) was noted. The common etiological factor observed was tobacco chewing. On histopathological features, cases were of leukoplakia 68.41%, oral lichen planus 13.16%, oral submucous fibrosis 7.90%, actinic cheilitis-7.9%, and oral erythroplakia 2.6%.
Conclusions: In this study, various oral premalignant lesions were observed. Their clinical and histopathological evaluation was done. Oral leukoplakia was most common lesion in the present study. Buccal mucosa was the most common site. Tobacco chewing habit was the common risk factor observed. Early detection of premalignant oral lesion is of utmost importance to prevent further morbidity as these lesions further progress to oral cancer.
References
Elango JK, Gangadharan P, Sumithra S, Kuriakose MA. Trends of head and neck cancers in urban and rural India. Asian Pacific J Cancer Prevention. 2006;7(1):108-12.
Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster randomized controlled trial. Lancet. 2005;365(9475):1927-33.
Warnakulasuriya S, Johnson NW, Waal VDI. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575-80.
Liu W, Shen ZY, Wang LJ, Hu YH, Shen XM, Zhou ZT, et al. Malignant potential of oral and labial chronic discoid lupus erythematosus: a clinicopathological study of 87 cases. Histopathol. 2011;59:292-8.
Mehrotra R, Gupta A, Singh M, Ibrahim R. Application of cytology and molecular biology in diagnosing premalignant and malignant oral lesions. Molecular Cancer. 2006;5(11):476-98.
Dietrich T, Reichart PA, Scheifelea C. Clinical risk factors of oral leucoplakia in a representative sample of the US population. Oral Oncol. 2004;40:158-63.
Mishra M, Mohanty J, SenguptaS, Tripathy S. Epidemiological and clinicopathological study of oral leucoplakia. Ind J Dermatol Venerol Leprosy. 2005;71(3):161-5.
Sharma P, Saxena S, Aggarwal P. Trends in the epidemiology of oral squamous cell carcinoma in western UP: an institutional study. Ind J Dent Res. 2010;21(3):316-9.
Mehta FS, Pindborg JJ, Gupta PC, Daftary DK. Epidemiologic and histologic study of oral cancer and leucoplakia among 50,915 villagers in India. Cancer. 1969;24:832-49.
Khandekar SP, Bagdey PS, Tiwari RR. Oral cancer and some epidemiological factors: A hospital based study. Indian J Community Med. 2006;31:157-9.
Fisher MA, Bouquot JE, Shelton BJ. Assessment of risk factors for oral leucoplakia in West Virginia. Community Dent Oral Epidemiol. 2005;33(1):45-52.
Axell T. Occurrence of leukoplakia and some other oral white lesions among 20,333 adult Swedish people. Community Dent Oral Epidemiol. 1987;15:46-51.
Terézhalmy GT, Huber MA, Jones AC, Sankar V, Noujeim M. Physical Evaluation in dental practice, Ed: 1st. Ames, Iowa: Wiley-Blackwell; 2009:170-171.
Kawabe R, Fujita K. Survival analysis: application to evaluation of risk factors for cancer development in oral leucoplakia. Japanese J Oral Mucosa. 2001;7:45-58.
Scully C, Carrozzo M. Oral mucosal disease: Lichen planus. Br J Oral Maxillofac Surg. 2008;46:15-21.
Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol. 2010;28:100-8.
van der Meij EH, Mast H, van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol. 2007;43:742-8.
Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucus fibrosis: review on aetiology and pathogenesis. Oral Oncol. 2006;42:561-8.
Pindborg JJ, Mehta FS, Gupta PC, Daftary DK. Prevalence of oral submucus fibrosis among 50,915 Indian Villagers. Br J Cancer. 1968;22:646-54.
Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol. 1985;13:340-1.
Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res. 2000;6:1702-10.
Reichart PA, Philipsen HP. Oral erythroplakia: a review. Oral Oncol. 2005;41:551-61.
